Drug Description in Trials / DrugBank / KEGG DRUG /


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
118F-AV-1451----3件: 5, 7, 127
218F-FDG1件: Fludeoxyglucose (18F)---13件: 5, 6, 7, 8, 13, 41, 46, 53, 84, 85, 96, 127, 300
318F-RO6958948----3件: 5, 7, 127
4ABBV-8E12----2件: 5, 7
5AL----10件: 5, 7, 13, 28, 51, 67, 86, 97, 114, 127
6Anti-Parkinson medication----5件: 5, 6, 7, 8, 17
7Apomorphine1件: Apomorphine2件: D02004 ,
D07460
2件: DRD1,
DRD2 💬
11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬3件: 5, 6, 7
8BIIB092----3件: 5, 7, 127
9BOTULINUM TOXIN TYPE A1件: Botulinum toxin type A1件: D00783 1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬10件: 2, 5, 6, 7, 13, 15, 17, 70, 113, 149
10Brain PET scan----3件: 5, 7, 127
11Davunetide1件: Davunetide1件: D09401 --3件: 5, 7, 127
12Davunetide (AL-108, NAP)1件: Davunetide1件: D09401 --3件: 5, 7, 127
13Deep Brain Stimulation----5件: 5, 6, 7, 8, 17
14Diagnostic Test: [18F]-RO6958948----5件: 5, 6, 7, 17, 127
15Diagnostic Test: Elecsys (Roche) Abeta42, Ttau and Ptau----5件: 5, 6, 7, 17, 127
16Diagnostic Test: Flutemetamol F18 Injection1件: Flutemetamol (18F)---5件: 5, 6, 7, 17, 127
17Diagnostic Test: Lumipulse (Fujirebio) Abeta42, Ttau and Ptau----5件: 5, 6, 7, 17, 127
18Dopamine1件: Dopamine2件: D00633 ,
D07870
5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬3件: 6, 7, 74
19Fasudil1件: Fasudil1件: D07941 2件: ROCK1,
ROCK2 💬
23件: Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬4件: 2, 5, 7, 51
20Flortaucipir1件: Flortaucipir1件: D11210 1件: MAPT 💬4件: Alzheimer disease, MAPK signaling pathway, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬3件: 5, 7, 127
21Flortaucipir F181件: Flortaucipir1件: D11210 1件: MAPT 💬4件: Alzheimer disease, MAPK signaling pathway, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬3件: 5, 7, 127
22Flutemetamol1件: Flutemetamol (18F)---5件: 5, 6, 7, 17, 127
23Flutemetamol F182件: Flutemetamol,
Flutemetamol (18F)
---5件: 5, 6, 7, 17, 127
24Leucine1件: Leucine1件: D00030 --11件: 5, 6, 7, 19, 65, 96, 97, 127, 283, 284, 299
25Lithium1件: Lithium citrate1件: D04749 --5件: 2, 5, 6, 7, 8
26NT 101----4件: 5, 6, 7, 17
27Other: 13C6 Leucine1件: Leucine1件: D00030 --3件: 5, 7, 127
28Raclopride1件: Raclopride---4件: 5, 6, 7, 17
29TPI 287 2 mg/m2----2件: 5, 7
30TPI-287 20 mg/m2----2件: 5, 7
31TPI-287 6.3 mg/m2----2件: 5, 7
32Vizamyl1件: Flutemetamol (18F)---3件: 5, 7, 127
33Vizamyl (flutemetamol(F-18))2件: Flutemetamol,
Flutemetamol (18F)
---3件: 5, 7, 127
34Xeomin1件: Botulinum toxin type A1件: D00783 1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬7件: 5, 6, 7, 13, 15, 17, 113